J Lamarche1, G Mailhot2,3. 1. Center for Interdisciplinary Research in Rehabilitation, CIUSS Centre-Sud-Montreal Gingras-Lindsay Rehabilitation Center, Montreal, QC, Canada. 2. Research Centre, CHU Sainte-Justine, Montreal, QC, Canada. 3. Department of Nutrition, Université de Montréal, Montréal, QC, Canada.
Abstract
STUDY DESIGN: Narrative review. OBJECTIVES: This review provides an overview of the etiological factors and consequences of vitamin D insufficiency in relation to spinal cord injury (SCI) as well as important considerations for vitamin D supplementation. SETTING: Montreal, Canada. METHODS: Literature search. RESULTS: Vitamin D insufficiency is common in SCI individuals owing to the presence of many contributing factors including limited sun exposure and intake, use of medication and endocrine perturbations. Although there are several biological plausible mechanisms by which vitamin D may act upon musculoskeletal and cardiometabolic health, the impact of vitamin D insufficiency on such systems remains ill defined in SCI. In the absence of guidelines for the management of vitamin D insufficiency in this high-risk population and in an attempt to provide clinical guidance, considerations for vitamin D supplementation such as the type of vitamin D, dosing regimens and toxicity are discussed and tentative recommendations suggested with particular reference to issues faced by SCI patients. CONCLUSION: Although high rates of vitamin D insufficiency are encountered in SCI individuals, its consequences and the amount of vitamin D required to prevent insufficiency are still unknown, indicating a need for more intervention studies with well-defined outcome measures. Routine screening and monitoring of vitamin D as well as treatment of suboptimal status should be instituted in both acute and chronic setting. The close interactions between vitamin D and related bone minerals should be kept in mind when supplementing SCI individuals, and practices should be individualized with clinical conditions.
STUDY DESIGN: Narrative review. OBJECTIVES: This review provides an overview of the etiological factors and consequences of vitamin Dinsufficiency in relation to spinal cord injury (SCI) as well as important considerations for vitamin D supplementation. SETTING: Montreal, Canada. METHODS: Literature search. RESULTS:Vitamin Dinsufficiency is common in SCI individuals owing to the presence of many contributing factors including limited sun exposure and intake, use of medication and endocrine perturbations. Although there are several biological plausible mechanisms by which vitamin D may act upon musculoskeletal and cardiometabolic health, the impact of vitamin Dinsufficiency on such systems remains ill defined in SCI. In the absence of guidelines for the management of vitamin Dinsufficiency in this high-risk population and in an attempt to provide clinical guidance, considerations for vitamin D supplementation such as the type of vitamin D, dosing regimens and toxicity are discussed and tentative recommendations suggested with particular reference to issues faced by SCI patients. CONCLUSION: Although high rates of vitamin Dinsufficiency are encountered in SCI individuals, its consequences and the amount of vitamin D required to prevent insufficiency are still unknown, indicating a need for more intervention studies with well-defined outcome measures. Routine screening and monitoring of vitamin D as well as treatment of suboptimal status should be instituted in both acute and chronic setting. The close interactions between vitamin D and related bone minerals should be kept in mind when supplementing SCI individuals, and practices should be individualized with clinical conditions.
Authors: Pankaj Arora; Yanna Song; Jeffery Dusek; Gregory Plotnikoff; Marc S Sabatine; Susan Cheng; Andre Valcour; Heather Swales; Beth Taylor; Erin Carney; Derek Guanaga; Joseph R Young; Courtney Karol; Michael Torre; Atum Azzahir; Semerit M Strachan; Dillon C O'Neill; Myles Wolf; Frank Harrell; Christopher Newton-Cheh; Thomas J Wang Journal: Circulation Date: 2014-10-30 Impact factor: 29.690
Authors: Y Maruyama; M Mizuguchi; T Yaginuma; M Kusaka; H Yoshida; K Yokoyama; Y Kasahara; T Hosoya Journal: Spinal Cord Date: 2008-01-22 Impact factor: 2.772
Authors: Mirjam M Oosterwerff; Elisabeth Mw Eekhoff; Natasja M Van Schoor; A Joan P Boeke; Prabath Nanayakkara; Rosa Meijnen; Dirk L Knol; Mark Hh Kramer; Paul Lips Journal: Am J Clin Nutr Date: 2014-06-04 Impact factor: 7.045
Authors: Michael F Holick; Rachael M Biancuzzo; Tai C Chen; Ellen K Klein; Azzie Young; Douglass Bibuld; Richard Reitz; Wael Salameh; Allen Ameri; Andrew D Tannenbaum Journal: J Clin Endocrinol Metab Date: 2007-12-18 Impact factor: 5.958
Authors: Frances M Weaver; Bella Etingen; Marylou Guihan; Cara Ray; Michael Priebe; Stephen Burns; Laura Carbone Journal: J Spinal Cord Med Date: 2019-12-20 Impact factor: 1.985
Authors: Anneke Hertig-Godeschalk; Martin W G Brinkhof; Anke Scheel-Sailer; Claudio Perret; Andreas Jenny; Gunter Landmann; Patrik O Wyss; Joelle Leonie Flueck Journal: BMJ Open Date: 2021-12-17 Impact factor: 2.692